Back
Day Range
$7.38
$7.71
52-Week Range
$4.55
$9.73
Volume
330,238
50D / 200D Avg
$7.56
/
$7.81
Prev Close
$7.20
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -4.2 | 0.4 |
| P/B | 9.1 | 2.9 |
| ROE % | -143.5 | 3.8 |
| Net Margin % | -444.1 | 3.9 |
| Rev Growth 5Y % | 20.9 | 10.0 |
| D/E | 1.3 | 0.2 |
Analyst Price Target
Hold
$18.00
+135.3%
Low: $16.00
High: $20.00
Forward EPS
-$1.13
Est. Revenue
120 M
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2029 |
$0.60
-$0.15 – $1.11
|
360 M | 1 |
| FY2028 |
-$0.54
-$1.46 – $0.80
|
210 M | 3 |
| FY2027 |
-$0.82
-$2.14 – $0.36
|
150 M | 3 |
Key Takeaways
Revenue grew 20.93% annually over 5 years — strong growth
Negative free cash flow of -109.45M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 116.49%
Growth
Revenue Growth (5Y)
20.93%
Revenue (1Y)137.42%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-143.48%
ROIC-80.69%
Net Margin-444.10%
Op. Margin-493.44%
Safety
Debt / Equity
1.25
Current Ratio2.03
Interest Coverage-12.37
Valuation
P/E Ratio
-4.17
P/B Ratio9.08
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 137.42% | Revenue Growth (3Y) | 44.58% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 20.93% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 33.28M | Net Income (TTM) | -147.79M |
| ROE | -143.48% | ROA | -54.79% |
| Gross Margin | 28.51% | Operating Margin | -493.44% |
| Net Margin | -444.10% | Free Cash Flow (TTM) | -109.45M |
| ROIC | -80.69% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 1.25 | Current Ratio | 2.03 |
| Interest Coverage | -12.37 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -4.17 | P/B Ratio | 9.08 |
| P/S Ratio | 18.50 | PEG Ratio | -0.07 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 615.76M | Enterprise Value | 596.89M |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 33.28M | 14.02M | 15.92M | 37.70M | 15.56M |
| Net Income | -147.79M | -84.03M | -129.62M | -79.56M | -57.99M |
| EPS (Diluted) | -2.12 | -1.49 | -3.16 | -1.63 | -1.43 |
| Gross Profit | 9.49M | 14.02M | 15.92M | 37.70M | 15.56M |
| Operating Income | -164.21M | -137.06M | -116.36M | -72.76M | -62.55M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 269.75M | 326.74M | 318.24M | 320.16M | 363.70M |
| Total Liabilities | 201.92M | 188.57M | 200.50M | 134.76M | 125.14M |
| Shareholders' Equity | 67.83M | 138.18M | 117.74M | 185.40M | 238.56M |
| Total Debt | 84.80M | 89.26M | 92.25M | 23.73M | 22.25M |
| Cash & Equivalents | 103.66M | 129.57M | 115.52M | 137.70M | 209.52M |
| Current Assets | 123.52M | 159.62M | 154.34M | 183.24M | 272.58M |
| Current Liabilities | 60.78M | 67.08M | 82.07M | 68.13M | 54.15M |